Aortic Dissection: Tight BP Control Avoids Late Reoperation


Major Finding: The rates of freedom from reoperation after aortic dissection repair among patients on beta-blocker therapy at 10 and 15 years were 86% and 83%, respectively, compared with 57% and 37% in patients not on the medication.

Data Source: A follow-up study of 252 patients who underwent repair of acute type A aortic dissection a single center during 1984-2009.

Disclosures: Dr. Melby said that he has no relevant financial interests.

BOCA RATON, FLA. – Beta-blocker therapy and strict, lifelong control of hypertension are key to avoiding late reoperation after repair of acute type A aortic dissection, according to a large, 25-year, single-center follow-up study.

Operative mortality was 16% among 252 patients who underwent repair of acute type A aortic dissection at the hands of 26 surgeons at Barnes-Jewish Hospital in St. Louis during 1984-2009. Of 28 variables that were scrutinized in a multivariate analysis, only one proved to be an independent risk factor for operative mortality: branch vessel malperfusion at presentation, with an associated 2.5-fold increased risk, Dr. Spencer J. Melby reported at the meeting.

Some 27 of 211 operative survivors required 30 late reoperations. Four variables were independently predictive of late reoperation: male sex, Marfan syndrome, not being on a beta-blocker at last follow-up, and systolic blood pressure (SBP) greater than 120 mm Hg, according to Dr. Melby of Washington University in St. Louis.

The rates of freedom from reoperation among patients on beta-blocker therapy at 10 and 15 years were 86% and 83%, respectively, compared with 57% and 37% in patients who were not on the medication.

Patients who maintained their SBP below 120 mm Hg had 10- and 15-year rates of freedom from reoperation of 92%. In those whose SBP was 120-140 mm Hg, the rates were 74% and 66%. In patients who maintained SBP above 140 mm Hg, the 10- and 15-year rates of freedom from reoperation were 49% and 30%.

In terms of perfusion techniques that were utilized in the initial repair, 35% of patients were placed on an aortic cross-clamp only, 30% had hypothermic cardiac arrest with retrograde cerebral perfusion, and 35% got hypothermic cardiac arrest without retrograde cerebral perfusion.

Importantly, long-term survival was not related to operative approach. Late survival was decreased, however, in patients with previous stroke or chronic renal insufficiency.

Discussant Dr. Thoralf M. Sundt III noted that although acute aortic dissection is an uncommon condition, it is nonetheless the most common fatal catastrophe of the aorta. Multiple studies over the years indicate that not much progress has been made in improving the high perioperative and long-term morbidity and mortality.

“We don't seem to be learning very much over time. It's not getting better. So a study such as this one that can impact the long-term results in these patients is important,” said Dr. Sundt, chief of cardiac surgery at Massachusetts General Hospital, Boston.

He particularly welcomed Dr. Melby's emphasis on lifelong beta-blocker therapy.

“It may seem a bit odd for surgeons to be focusing on pharmacologic treatment, but in fact aortic disease is really a disease that's most often treated by surgeons. There are few medical vascular specialists, and so it really is important for us to follow these patients. This is a chronic condition, and we ought to adopt a posture towards that condition where we are responsible for caring for these patients over time,” according to the surgeon.

Dr. Melby added that “one of the conclusions of our paper is that because we found [that] long-term outcomes were independent of the technique, it's safe to say that surgeons should treat this problem in the way they're most comfortable.”

Recommended Reading

FDA: No Increased Cancer Risk With ARBs
MDedge Cardiology
Updated JNC Guidelines May Address Individualization of BP Goals
MDedge Cardiology
Azilsartan Beats Olmesartan at Reducing Blood Pressure in Type 2 Hypertension
MDedge Cardiology
Carvedilol Reduces Intradialytic Hypertension
MDedge Cardiology
Intensive BP Therapy May Cut Fracture Risk
MDedge Cardiology
KEEP Results Show Promise of New Equation
MDedge Cardiology
Two ARB-Based Regimens Found Equivalent in OSCAR
MDedge Cardiology
Secondhand Smoke Raises Boys' Blood Pressure
MDedge Cardiology
Prior Preeclampsia Boosts Hypertension Risk
MDedge Cardiology
Mom's Smoking Ups Children's CVD Risk
MDedge Cardiology